RF
54
4
TRIP
52
3
LYB
50
-3
DTE
47
-2
CME
37
3
NOV
60
2
TAP
43
2
RHI
40
2
F
54
3
DLTR
51
3
NAVI
41
6
CL
70
-4
AKAM
53
3
C
46
3
HP
44
3
CFG
50
8
SLG
77
3
LRCX
77
2
LEG
22
6
DO
47
-2
RF
54
4
TRIP
52
3
LYB
50
-3
DTE
47
-2
CME
37
3
NOV
60
2
TAP
43
2
RHI
40
2
F
54
3
DLTR
51
3
NAVI
41
6
CL
70
-4
AKAM
53
3
C
46
3
HP
44
3
CFG
50
8
SLG
77
3
LRCX
77
2
LEG
22
6
DO
47
-2
Financhill
Back

AAM S&P Emerging Markets Hi Div Val ETF Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
56

EEMD
AAM S&P Emerging Markets Hi Div Val ETF

Last Price:
18.29
Seasonality Move:
-4.66%
Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
242.97
Seasonality Move:
20.36%
Buy
56
AAM S&P Emerging Markets Hi Div Val ETF (EEMD) is a Buy

Is AAM S&P Emerging Markets Hi Div Val ETF a Buy, Sell or Hold?

  • The current AAM S&P Emerging Markets Hi Div Val ETF [EEMD] share price is $18.28. The Score for EEMD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EEMD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EEMD Stock Price Chart

What is AAM S&P Emerging Markets Hi Div Val ETF's stock price today?

  • The AAM S&P Emerging Markets Hi Div Val ETF share price today is $18.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEMD is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $243.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.

EEMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 40.81 Sell
Chaikin Money Flow: -815 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.2 - 18.86) Sell
Bollinger Bands (100): (18.23 - 19.05) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.91 Buy
Relative Strength Index (14 RSI): 86.77 Buy
Chaikin Money Flow: -1210062 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.8 - 205.74) Buy
Bollinger Bands (100): (136.44 - 176.64) Buy

EEMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.37 Sell
20-day SMA: 18.39 Sell
50-day SMA: 18.64 Sell
200-day SMA: 18.54 Sell
8-day EMA: 18.33 Sell
20-day EMA: 18.44 Sell
50-day EMA: 18.57 Sell
200-day EMA: 18.52 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.44 Buy
20-day SMA: 176.25 Buy
50-day SMA: 159.62 Buy
200-day SMA: 165.96 Buy
8-day EMA: 218.01 Buy
20-day EMA: 188.75 Buy
50-day EMA: 168.9 Buy
200-day EMA: 168.09 Buy

AAM S&P Emerging Markets Hi Div Val ETF Earnings Growth & EEMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.

AAM S&P Emerging Markets Hi Div Val ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):